William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Verve Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation (FLAC) Announce Merger Agreement
-
NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiom
-
UPDATE: William Blair Starts SS&C Technologies Holdings, Inc. (SSNC) at Outperform
-
UPDATE: William Blair Starts SEI Investments (SEIC) at Market Perform
-
UPDATE: William Blair Starts AssetMark Financial Holdings Inc. (AMK) at Outperform
-
UPDATE: William Blair Starts Envestnet (ENV) at Outperform
-
VistaGen (VTGN) Downgraded at William Blair on PALISADE-1 Failure, "Uncertainty on Path Forward for PH94B"
-
William Blair Expands Tech-Enabled Services Coverage With Three Senior Investment Banking Hires
-
Leading Atlassian Partner Valiantys Secures Investment from Tercera to Expand Its Global Reach
-
Verve Therapeutics (VERV) Prices Upsized 8.33M Share Offering at $27/sh
-
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
Verve Therapeutics (VERV) Announces Proposed $200M Share Offering
-
Verve Therapeutics Announces Proposed Public Offering of Common Stock
-
Verve Therapeutics Announces Proposed Public Offering of Common Stock
-
Form D/A William Blair: Non-US
-
StepStone Group (STEP) and RedBird Capital Acquire Talent Systems
-
RedBird Capital Partners to Acquire Talent Systems, The Industry’s Premier Tech-Driven Global Casting Marketplace
-
Trinity Life Sciences Acquires D Cube Analytics
-
Fidelity Payment Services Announces Strategic Growth Investment from PSG
-
El Car Wash Announces Acquisition by Warburg Pincus
-
UPDATE: William Blair Downgrades 10X Genomics (TXG) to Market Perform
-
IMF hopes to soon resume Sri Lanka high-level discussions
-
Concord Health Partners Expands Senior Team, Adds Healthcare Investment Veterans Erik Larsen and Derek Schmidt
-
William Blair Reiterates Outperform Rating on Xenon Pharmaceuticals (XENE)
-
9 Meter (NMTR) is "Developing Potentially Best-in-class SBS Agent" - William Blair Reiterates Outperform Rating
-
William Blair Reiterates Outperform Rating on VistaGen Therapeutics (VTGN)
-
William Blair Says 'Buy the Dip' in Verra Mobility (VRRM)
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497 WILLIAM BLAIR FUNDS
-
Xenon Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2022
-
Xenon Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2022
-
D.A. Davidson Expands Its Financial Sponsors Coverage with New Hire Nick Ramtin, Managing Director
-
Codiak BioSciences to Participate at William Blair Biotech Focus Conference 2022
-
MidOcean Partners Acquires Pragmatic Institute, an Industry Leading Provider of Professional Training in Fast Growing Product Management, Data and Digital Design Fields
-
Atea Pharmaceuticals Participates in the William Blair Biotech Focus Conference
-
Form D/A William Blair Internatio
-
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2022
-
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2022
-
Form D/A William Blair Emerging
-
Rocket Pharmaceuticals to Present at William Blair Biotech Focus Conference
-
Bionomics to Participate in William Blair’s Biotech Focus Conference 2022
-
Kezar Life Sciences to Present at the William Blair Biotech Focus Conference
-
Vaccitech to Present at the William Blair Biotech Focus Conference 2022
-
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Participate at William Blair Biotech Focus Conference 2022
-
VistaGen to Participate at William Blair Biotech Focus Conference 2022
-
Tempest to Participate in Panel Discussion at 2022 William Blair Biotech Focus Conference
-
Tempest to Participate in Panel Discussion at 2022 William Blair Biotech Focus Conference
-
Vedanta Biosciences to Present at Upcoming Investor Conferences

